Cosmax BTI-Organoid Science, MOU for Hair Regeneration Treatment

At the business agreement signing ceremony held on the 4th at the Cosmax R&I Center in Seongnam-si, Gyeonggi Province, Kang Seung-hyun, head of the Cosmax BTI Bio Convergence Research Institute (from the left), and Yoo Jong-man, CEO of Organoid Science, are taking a commemorative photo after signing the business agreement. Photo by Organoid Science

[Asia Economy Reporter Kim Young-won] Organoid Science, a company specializing in organoid-based regenerative therapeutics and efficacy evaluation, announced on the 18th that it has signed a memorandum of understanding (MOU) with COSMAX BTI and has begun joint research and development of hair regeneration therapeutics and skin organoids.

On the 4th, the two companies signed the MOU at the COSMAX R&I Center in Seongnam-si, Gyeonggi-do, agreeing to collaborate on advancing hair regeneration therapeutics and skin organoid fields based on organoids. They plan to establish a joint research relationship aimed at developing innovative products and services to be introduced to the market in the future.

COSMAX BTI holds patents and conducts research on cosmetic manufacturing and skin efficacy ingredients. Organoid Science explained that since the company is developing a skin organoid and efficacy evaluation platform, this joint research is expected to yield meaningful results in establishing a hair efficacy evaluation system for the development of hair regeneration therapeutics.

Organoids are next-generation technology that excellently mimic the human body by reproducing cellular composition, structure, and functional specificity, and are gaining attention as an alternative animal testing technology in various research fields of the bioindustry and medical sectors.

Yoo Jong-man, CEO of Organoid Science, stated, "Because organoids can more accurately predict the effects and efficacy on actual skin, the cosmetics field among many research areas will see the most rapid development. Based on organoid technology, we expect accurate and safe hair regeneration therapeutics to be commercialized, creating a significant impact not only in the domestic market but also globally."

Kang Seung-hyun, head of research at COSMAX BTI, said, "Skin organoids are models that approach reality more closely than commonly used skin models, and in cosmetic evaluation, this brings us one step closer to securing customer trust."

This content was produced with the assistance of AI translation services.